- Report
- June 2023
- 84 Pages
Global
From €3500EUR$4,188USD£3,086GBP
- Report
- May 2022
- 135 Pages
Global
From €2238EUR$2,500USD£1,906GBP
From €995EUR$1,191USD£877GBP
The Sleep Disorder Drug market is a subset of the Central Nervous System Drugs market. It includes drugs used to treat a variety of sleep disorders, such as insomnia, narcolepsy, and sleep apnea. These drugs are typically classified as hypnotics, sedatives, or anxiolytics, and can be prescribed in the form of tablets, capsules, or liquids. Commonly prescribed sleep disorder drugs include benzodiazepines, non-benzodiazepines, and melatonin receptor agonists.
The Sleep Disorder Drug market is highly competitive, with many companies offering a variety of products. Some of the major players in the market include Pfizer, Sanofi, Merck, GlaxoSmithKline, Novartis, and Takeda. Other companies include Sunovion, Jazz Pharmaceuticals, and Teva Pharmaceuticals. Show Less Read more